13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-04-02 Event 2025-03-31 SEC 0000950170-25-049860 →

Sullivan Lara → Pyxis Oncology, Inc. PYXS

Stake: 11.21% Shares: 7,543,007 CUSIP: 747324101 Class: Common Stock, par value $0.001 per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 19/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%
  • Passive Schedule 13G filer baseline
  • High conviction ownership stake (11.2%)
  • Held by 1 tracked 13F institutional manager
  • Moderate short days-to-cover (3.5 DTC)

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 3 of this Amendment No. 5 is incorporated by reference herein.

Cross-References

Insider Activity (last 365d)
1 transaction
1 buys · 0 sales · 0 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-10-15
DTC 3.47
4,345,953 shares short · -11.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $216K
Point72 Asset Mgmt

Post-Filing Returns · since 2025-03-31 on PYXS

+1 day
0.0%
+5 days
0.0%
+30 days
0.0%
+60 days
0.0%
+90 days
0.0%
+180 days
0.0%

Anchor price 3.07 on closest trading day on/after 2025-03-31. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-04 Civik Thomas director, officer Award 2,503,050 $3.89 $9.74M

Other 13D/G Filings on Pyxis Oncology, Inc.

FiledFormFilerStakeShares
2026-10-05 SCHEDULE 13G Coastlands Capital LP — — view →
2026-10-02 SCHEDULE 13G/A GordonMD Global Investments LP — — view →
2026-07-10 SCHEDULE 13G BIOTECHNOLOGY VALUE FUND L P — — view →
2026-07-02 SCHEDULE 13G/A GordonMD Global Investments LP — — view →
2023-04-04 SC Sullivan Lara — — view →

Other Filings by Sullivan Lara

FiledFormIssuerStakeShares
2023-04-04 SC Pyxis Oncology, Inc. PYXS — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →